Periodical (Journal)

ISSN  :   1758-4272 ( Print )   |   1758-4280 ( Online )   Active
Aim & Scope

International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education. The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies. The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology and different types of radiological studies. International Journal of Clinical Rheumatology is a wide construct journal established in light of two key principles: to distribute the most energizing looks into in the field of dependence and restorative answers for it : Second to give a quick pivot time feasible for exploring and distributed of articles uninhibitedly for exploration, instructing and reference purposes.The journal is fully associated with the clinical practitioners, therapeutic/wellbeing specialists, understudies, experts & scientists and expert bodies & establishments. Topics covered include: Drug therapy in Rheumatology; Clinical diagnosis in Polymyalgia Rheumatica, Palindromic Rheumatism & Relapsing Polychondritis; Clinical trials, care and research in Rheumatology; Clinical manifestations of Rheumatoid Arthritis; Immunological mechanism and IgG4-related diseases; Orthopedics, spine and soft tissue rheumatics disorders; Pediatric Rheumatology, Geriatric Rheumatology and risk of infection; Sceleroderma and related systemic rheumatic diseases; Systemic scelorosis, Dermatomyositis, Polymyositis & Seronegative Spondyoarthropathy; Antimalarial drugs in the treatement of rheumatic diseases (Lupus erythematosus and Sjogren's syndrome); Developing treatment choices, such as gene and stem cell therapy (Bispecific monoclonal antibodies & regulatory T-cell); Vasculitis, osteoarthritis and immune mechanism in Rheumatology. Articles received for publication in International Journal of Clinical Rheumatology, are critically reviewed by two independent referees on a double-blind basis. Authors thereby requested to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article [1]

Go to Website

Continuations / Journal History
(  2006  -  2008  ) Future Rheumatology (  2009  -  9999  ) International Journal of Clinical Rheumatology
2019 - VOLUME 14, ISSUE 1
9 RESULTS in 19 msec
not available

Relapsing IgG4-related orbital inflammatory pseudotumor after achieving success with rituximab

No authors listed.

International Journal of Clinical Rheumatology , 2019 - VOLUME 14, ISSUE 1

10.4172/1758-4272.1000224

0 0

not available

Disease flares, damage accrual and survival in ANCA-associated vasculitis in Western Australia

No authors listed.

International Journal of Clinical Rheumatology , 2019 - VOLUME 14, ISSUE 1

10.4172/1758-4272.1000221

1 0

not available

Mobile health applications in rheumatology: Could they improve our care and research?

No authors listed.

International Journal of Clinical Rheumatology , 2019 - VOLUME 14, ISSUE 1

10.4172/1758-4272.1000223

1 0

not available

Genetic markers in HLA region to identify patients with tuberculosis risk, in RA subjects

No authors listed.

International Journal of Clinical Rheumatology , 2019 - VOLUME 14, ISSUE 1

10.4172/1758-4272.1000218

0 0